CVS Health Corporation income statement & cash flow
In the fiscal year ended Dec 31, 2025, CVS Health Corporation reported net income of $1.77B on revenue of $402.07B. Operating cash flow was $10.64B and capital expenditures were $2.83B, leaving $7.81B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $177.55B | $184.79B | $194.58B | $256.78B | $268.71B | $292.11B | $322.47B | $357.78B | $372.81B | $402.07B |
| Gross profit | $28.86B | $28.55B | — | — | — | — | — | — | — | — |
| Operating income | $10.39B | $9.54B | $4.02B | $11.99B | $13.91B | $13.31B | $7.95B | $13.74B | $8.52B | $4.66B |
| Net income | $5.32B | $6.62B | −$594.00M | $6.63B | $7.18B | $8.00B | $4.31B | $8.34B | $4.61B | $1.77B |
| Diluted EPS | $4.90 | $6.44 | −$0.57 | $5.08 | $5.46 | $6.02 | $3.26 | $6.47 | $3.66 | $1.39 |
| Operating cash flow | $10.14B | $8.01B | $8.87B | $12.85B | $15.87B | $18.27B | $16.18B | $13.43B | $9.11B | $10.64B |
| Capital expenditures | $2.22B | $1.92B | $2.04B | $2.46B | $2.44B | $2.52B | $2.73B | $3.03B | $2.78B | $2.83B |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | — | 1.2% | 0.4% |
| Dec 2024 | — | 2.3% | 1.2% |
| Dec 2023 | — | 3.8% | 2.3% |
| Dec 2022 | — | 2.5% | 1.3% |
| Dec 2021 | — | 4.6% | 2.7% |
Source: SEC EDGAR XBRL company facts for CIK 64803 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.